Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Semaglutide Injection

Approval Number

国药准字SJ20240021

CompanyNovo Nordisk A/S

Registration Date

June 18, 2024

Drug Information

Generic Name

司美格鲁肽注射液

Trade Name

诺和盈

Dosage Form

注射剂

Strength

2.27mg/ml，3ml

Drug Type

生物制品

Registration Date

June 18, 2024

Expiry Date

June 17, 2029

Company Information

Applicant Company

Company NameNovo Nordisk A/S

Company Address

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Company NameNovo Nordisk A/S

Company Address

Novo Alle, DK-2880 Bagsvaerd, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy